Latest Insider Transactions at Oncocyte Corp (OCX)
This section provides a real-time view of insider transactions for Oncocyte Corp (OCX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oncocyte Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oncocyte Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
47,976
+12.03%
|
$47,976
$1.34 P/Share
|
|
Dec 11
2020
|
Mitchell S Levine Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,121
+17.81%
|
-
|
|
Dec 11
2020
|
Alfred D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,909
+1.91%
|
-
|
|
Dec 11
2020
|
Cavan M. Redmond Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,416
+20.63%
|
-
|
|
Dec 11
2020
|
Albert P Parker COO |
BUY
Grant, award, or other acquisition
|
Direct |
5,586
+34.54%
|
-
|
|
Dec 11
2020
|
Douglas T. Ross Former CSO |
BUY
Grant, award, or other acquisition
|
Direct |
5,317
+50.0%
|
-
|
|
Dec 11
2020
|
Padmavathi Sundar Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,177
+50.0%
|
-
|
|
Dec 11
2020
|
Andrew J. Last Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,184
+41.12%
|
-
|
|
Dec 11
2020
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,602
+7.89%
|
-
|
|
Dec 11
2020
|
Lyndal K. Hesterberg CSO |
BUY
Grant, award, or other acquisition
|
Direct |
6,603
+46.9%
|
-
|
|
Apr 24
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Apr 24
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,050,000
+6.66%
|
$2,100,000
$2.27 P/Share
|
|
Jan 02
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 02
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,391,466
+4.96%
|
$2,782,932
$2.16 P/Share
|
|
Nov 13
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Nov 13
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,176,471
+8.75%
|
$1,176,471
$1.7 P/Share
|
|
Sep 11
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 11
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,000,000
+15.27%
|
$2,000,000
$1.66 P/Share
|
|
Jul 02
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
$0
$2.0 P/Share
|
|
Jul 02
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000,000
+9.9%
|
$2,000,000
$2.0 P/Share
|
|
Feb 08
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
$0
$3.75 P/Share
|
|
Feb 08
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
533,333
+6.18%
|
$1,599,999
$3.75 P/Share
|
|
Mar 28
2018
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
$0
$1.26 P/Share
|
|
Mar 28
2018
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,968,254
+34.41%
|
$3,968,254
$1.26 P/Share
|